[Clostridium] symbiosum

Information

Microbe Identification

[Clostridium] symbiosum

Microbe id: PMDBM2020205
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: [Clostridium] symbiosum [1512]
Taxonomy Genus: Clostridium [1485]
Taxonomy Family: Clostridiaceae [31979]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of [Clostridium] symbiosum

Identified MGC Region
(click for details)
MGC Cluster (Most Similar) Similarity Compound metabolized by the MGC Type of MGC Reference(PubMed ID)
Unclassified gene clustern.a.TPP fatty acidsPMID: 36782070
Unclassified gene clustern.a.Others HGD unassignedPMID: 36782070
Leucine reductive branch C. sporogenesn.a.Others HGD unassignedPMID: 36782070
Histidine to glutamate K. pneumoniaeHistidineHistidine to glutamate hutHGIU operonPMID: 22933560
Ethanolamine degradation S. typhimuriumEthanolamineEUT pathwayPMID: 20234377
Succinate to propionate A. sp. KLE1797SuccinateSuccinate to propionatePMID: 24553467
Aminobutyrate to butyrate C. pasteurianumAminobutyrateAminobutyrate to ButyratePMID: 27994578
Leucine reductive branch C. sporogenesLeucine / choline/proline/tryptophan/Tyr/Phe/leucine/valineLeucine reductionPMID: 15654892 / PMID: 31831639
Glycine reductase C. sticklandiiGlycineGlycine reductasePMID: 11271425
Acetate to butyrate C. sporogenesAcetateAcetate to butyratePMID: 17241242
Pyruvate to acetate and formate C. acetobutylicumPyruvatePyruvate to acetate-formatePMID: 20622067
Glutamate to butyrate C. symbiosumGlutamate / n.a.Glutamate to butyric,Others HGD unassignedPMID: 27994578 / PMID: 36782070
Arginine2putrescine R. gnavusPutrescine / argininePutrescine to spermidine,Arginine to putrescinePMID: 30183487 / PMID: 30183487
Rnf complex C. sporogenesEnergy-capturing-relatedRnf complexPMID: 23269825

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of [Clostridium] symbiosum


Identified BGC Region
(click for details)
BGC Cluster (Most Similar) Similarity Compound Synthesized by the BGC Type of BGC Reference (PubMed ID)
Unclassified gene clustern.a.RanthipeptidePMID: 34019648

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of [Clostridium] symbiosum distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of [Clostridium] symbiosum in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of [Clostridium] symbiosum

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗2.72444631223195mNGS
Kidney Failure, Chronic PRJEB65297🔗2.92851138367818mNGS
Hypertension PRJNA509999🔗2.81843105262738mNGS
Dwarfism PRJNA808649🔗-3.01714186625558mNGS
Colorectal Neoplasms PRJNA1167935🔗2.7395213242223mNGS
Colorectal Neoplasms PRJNA888860🔗2.87871266428038mNGS
Colorectal Neoplasms PRJNA763023🔗2.97901856220464mNGS
Colorectal Neoplasms PRJNA1138893🔗3.13798537407556mNGS
Colorectal Neoplasms PRJNA731589🔗3.21426043246018mNGS
Diabetes Mellitus, Type 1 PRJNA893406🔗2.50356019282228mNGS
Colitis, Ulcerative PRJNA398089🔗-2.58507595530463mNGS
Colitis, Ulcerative PRJNA993675🔗2.79817193903434mNGS
Colitis, Ulcerative PRJEB76677🔗3.04934332774121mNGS
Campylobacter Infections PRJNA660443🔗3.8858470274537mNGS
Schizophrenia PRJNA1135717🔗2.85140654941656mNGS
Crohn Disease PRJNA813736🔗2.46441518850226mNGS
Crohn Disease PRJNA398089🔗2.68730961850695mNGS
Crohn Disease PRJNA993675🔗3.34789958983698mNGS
Polycystic Ovary Syndrome PRJNA530971🔗-3.07276009190886mNGS
Arthritis, Rheumatoid PRJNA896336🔗3.41520581748347mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗2.4570709731097mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗2.6866973281608mNGS
Anorexia PRJNA674716🔗3.23188369127003mNGS
Neuroblastoma PRJEB63351🔗3.42366158276802mNGS
Irritable Bowel Syndrome PRJNA705217🔗3.06743619813325mNGS
Peutz-Jeghers Syndrome PRJNA905444🔗2.23096699937113mNGS
Gastroesophageal Reflux PRJNA993632🔗2.09522880791063mNGS
Cystic Fibrosis PRJNA314903🔗3.57417336089303mNGS
Obesity PRJNA1125836🔗2.32871880343213mNGS
Autism Spectrum Disorder PRJNA686821🔗2.94685804459452mNGS
Autism Spectrum Disorder PRJNA1037036🔗2.9891721935241mNGS
Biliary Atresia PRJNA730640🔗-3.4132155940203mNGS
Renal Insufficiency, Chronic PRJEB65297🔗2.79071224981588mNGS
Multiple Sclerosis PRJEB28543🔗2.91202813498428mNGS
COVID-19 PRJDB13214🔗2.60275179551589mNGS
COVID-19 PRJNA624223🔗3.86390222857228mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by [Clostridium] symbiosum



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the [Clostridium] symbiosum



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by [Clostridium] symbiosum

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
1Clostridium_symbiosum_WAL_14163 Download
2Clostridium_symbiosum_WAL_14673 Download
3Clostridium_symbiosum_ATCC_14940 Download

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by [Clostridium] symbiosum


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the [Clostridium] symbiosum



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of [Clostridium] symbiosum

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by [Clostridium] symbiosum

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by [Clostridium] symbiosum

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
1Clostridium_symbiosum_WAL_14163 View
2Clostridium_symbiosum_WAL_14673 View
3Clostridium_symbiosum_ATCC_14940 View

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by [Clostridium] symbiosum



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the [Clostridium] symbiosum


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe [Clostridium] symbiosum


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?